Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘infectious disease’ Category

Journal makes it official, retracting controversial autism-vaccine paper

with 19 comments

translational neurodegenerationA little more than a month after removing a highly criticized article that claimed the measles-mumps-rubella (MMR) vaccine increased the risk of autism in African American boys, Translational Neurodegeneration has officially retracted the paper.

Here’s the notice, dated yesterday: Read the rest of this entry »

Publisher issues statement of concern about HIV denial paper, launches investigation

with 49 comments

frontiers phThe publisher Frontiers has issued a Statement of Concern about a paper denying that HIV causes AIDS, and has launched an investigation into how the paper was published in the first place.

The paper, “Questioning the HIV-AIDS hypothesis: 30 years of dissent,” is written by Patricia Goodson of Texas A&M University and was published on September 23 in Frontiers in Public Health. As Tara Smith, who blogged about the paper yesterday, notes: Read the rest of this entry »

Written by Ivan Oransky

September 26th, 2014 at 1:00 pm

Image manipulation forces retraction of hepatitis C paper

without comments

ljii20.v032.i04.coverA group of researchers from Egypt has lost their 2013 article on hepatitis C in the Journal of Immunoassay and Immunochemistry for fudging their figures.

The article was titled “In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.” According to the abstract: Read the rest of this entry »

Publisher updates with more info on staph retraction

with 2 comments

cidWe brought you this story last week, about a paper on drug resistant staph being retracted for a lab error. Now, we’ve got an update from Rachel Safer, senior editor for medical journals at Oxford University Press, where the paper was published.

Apparently, the researchers “inadvertently relied upon the use of a test system that was not approved for the microorganism studied in their paper,” leading to the retraction, and the corresponding author of the study wasn’t initially all that responsive:

Read the rest of this entry »

Written by Cat Ferguson

September 17th, 2014 at 11:30 am

87% of bugs resistant to antibiotics? Not so fast, as staph paper yanked after staff mistake

with 3 comments

What could have been a truly scary study about drug resistant staph infections in hospitals has been retracted due to a lab error.

6.coverResearchers at a community hospital in Pittsburgh claimed that the commonly quoted 3% rate of staph that is resistant to ceftriaxone and sensitive to methicillin was drastically understated. However, an “honest error in the interpretation of a key lab test” called the findings into question.

Here’s the abstract: Read the rest of this entry »

Journal that “suffered” from plagiarism purges itself

with 7 comments

pharmpractWhen Pharmacy Practice found out it had been victimized by plagiarists, it apparently took the news personally — and to heart.

In an elaborate statement with more than a dozen references — but not one to the plagiarizing work — the journal lashed out against the behavior of word thieves, and described the discovery as a Road to Damascus moment.

Here’s the notice, which was published in 2012 but was only just indexed on PubMed:

Read the rest of this entry »

Written by amarcus41

August 22nd, 2014 at 11:10 am

Second study of widely touted cancer and HIV “cure” retracted

with 4 comments

j med virologyLast month, we brought you the story of the retraction of a paper by Nobutu Yamamoto and colleagues about “a protein being used — unapproved by health agencies — to treat diseases including cancer and autism.”

A second paper by the group, about using the protein to treat HIV, has been retracted. Here’s the notice for “Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF),” from the Journal of Medical Virology:
Read the rest of this entry »

Written by Ivan Oransky

August 21st, 2014 at 4:00 pm

Authors retract highly cited XMRV-prostate cancer link paper from PNAS

with 6 comments

pnas 1113Retraction Watch readers may recall that nearly two years ago, an editor at PLOS declared the scientific story of a link between XMRV, aka xenotropic murine leukemia-related virus, and prostate cancer over, saying that a retraction from PLOS Pathogens was the “final chapter.” (That retraction led to an apology from the journal about how it was handled.)

Perhaps, however, there is an epilogue. This week, a group of authors who published a highly cited 2009 study in the Proceedings of the National Academy of Sciences (PNAS) making the same link retracted it. Here’s the notice, signed by all five authors: Read the rest of this entry »

Written by Ivan Oransky

August 12th, 2014 at 8:33 am

Unusual: HIV vaccine researcher who faked data arrested, faces felony charges

with 21 comments

US Attorney Nicholas Klinefeldt

Dong Pyou-Han, a former researcher at Iowa State University who spiked rabbit blood samples to make it look as though a potential HIV vaccine was working, was arrested earlier this week on felony charges.

According to the Des Moines Register: Read the rest of this entry »

Written by Ivan Oransky

June 20th, 2014 at 8:30 am

Journal retracts stem cell study despite objections of most authors

with one comment

Gerold Feuer in 2008, via Upstate

Gerold Feuer in 2008, via Upstate

The journal Blood has retracted a 2010 paper over the objections of most of its authors, two of whom were found by their university to have used “fraudulent methods” to obtain the data.

We first reported on the case of Gerold Feuer last fall. The State University of New York (SUNY) Upstate Medical Center in Syracuse fired Feuer in 2010 after determining that he had misused state funds to enrich a company he had founded, HuMurine. A court agreed with many of the university’s claims, but ordered his reinstatement in 2012.

Meanwhile, as we noted last fall: Read the rest of this entry »